1. m-TOR inhibitors: What role in liver transplantation?
Toshiyasu Kawahara, Sonal Asthana, Norman M. Kneteman 
Journal of Hepatology 
Volume 55, Issue 6, Pages (December 2011)
DOI: /j.jhep
Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1 Structures of sirolimus and everolimus.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
An overview of the m-TOR signaling pathway and relative activities.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

4. Fig. 3
Glomerular filtration rate (GFR) either with everolimus or cyclosporine A after liver transplantation. Significantly improved GFR was observed in the everolimus group from 1month after liver transplantation with early withdrawal of cyclosporine A. [28].
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

5. Fig. 4
Creatinine clearance with everolimus or cyclosporine A after liver transplantation. Stable, but not improved renal function was observed after conversion from a calcineurin inhibitor to everolimus a relatively long mean time post-liver transplant (>3years) [29].
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2011 European Association for the Study of the Liver Terms and Conditions